Cargando…

Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study

BACKGROUND: Currently many TKA protocols rely on multimodal analgesic protocols with patient-controlled analgesia systems that administer opioids through a patient controlled IV infusion pump, in addition to concomitant peripheral nerve blocks and local anesthetics. Although effective, PCA IV opioid...

Descripción completa

Detalles Bibliográficos
Autores principales: Scardino, Marco, D’Amato, Tiziana, Martorelli, Federica, Fenocchio, Giorgia, Simili, Vincenzo, Di Matteo, Berardo, Bugada, Dario, Kon, Elizaveta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861254/
https://www.ncbi.nlm.nih.gov/pubmed/29557999
http://dx.doi.org/10.1186/s40634-018-0123-y
_version_ 1783308061205594112
author Scardino, Marco
D’Amato, Tiziana
Martorelli, Federica
Fenocchio, Giorgia
Simili, Vincenzo
Di Matteo, Berardo
Bugada, Dario
Kon, Elizaveta
author_facet Scardino, Marco
D’Amato, Tiziana
Martorelli, Federica
Fenocchio, Giorgia
Simili, Vincenzo
Di Matteo, Berardo
Bugada, Dario
Kon, Elizaveta
author_sort Scardino, Marco
collection PubMed
description BACKGROUND: Currently many TKA protocols rely on multimodal analgesic protocols with patient-controlled analgesia systems that administer opioids through a patient controlled IV infusion pump, in addition to concomitant peripheral nerve blocks and local anesthetics. Although effective, PCA IV opioids do not provide optimal results with fast track rehabilitation protocols. METHODS: The present is a retrospective study comparing the novel sublingual sufentanil PCA system (SSTS) to our standard of care foreseeing continuous femoral nerve block (cFNB) within a multimodal analgesic in a TKA fast-track protocol. The study evaluated 95 patients on SSTS (SSTS group) and 87 on cFNB (cFNB/control group) and collected data on numeric rating scores for pain from day 1–3 after surgery (T1, T2, T3), both at rest (NRS) and during movement (mNRS), patient’s ability to walk, need for supplementary analgesia (rescue dose), occurrence of adverse effects, length of hospital stay, and usability rating for SSTS by both patients and hospital staff. RESULTS: NRS at rest was lower in the cFNB than in the SSTS group for all 3 days after surgery, whereas mNRS scores were lower in the SSTS group at all time points measured. Adverse effects were significantly fewer among patients of the SSTS group (6% patients) than those of the cFNB (74% patients) (p <  0.001). Rescue doses were needed by 5% of SSTS patients vs 60% of cFNB. The fewer adverse events and lower pain scores for the SSTS group were associated to a notably better ability to ambulate, with all patients (100%) of the SSTS group being able to stand and walk for 10 m from T1 on; patients in the cFNB group showed a slower recovery with only 40% being able to stand and walk on T1, 70% on T2 and 85% on T3. All patients of the SSTS group had a length of stay of 4 days (day of surgery plus 3 after) as foreseen by the fast track protocol, in comparison only 36% of cFNB. Lastly, patient and nursing staff judged SSTS easy to use. CONCLUSION: Our experience suggests that SSTS is a valuable strategy for routine postoperative analgesia following TKA in the context of a multimodal analgesic approach within the fast-track setting.
format Online
Article
Text
id pubmed-5861254
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-58612542018-03-23 Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study Scardino, Marco D’Amato, Tiziana Martorelli, Federica Fenocchio, Giorgia Simili, Vincenzo Di Matteo, Berardo Bugada, Dario Kon, Elizaveta J Exp Orthop Research BACKGROUND: Currently many TKA protocols rely on multimodal analgesic protocols with patient-controlled analgesia systems that administer opioids through a patient controlled IV infusion pump, in addition to concomitant peripheral nerve blocks and local anesthetics. Although effective, PCA IV opioids do not provide optimal results with fast track rehabilitation protocols. METHODS: The present is a retrospective study comparing the novel sublingual sufentanil PCA system (SSTS) to our standard of care foreseeing continuous femoral nerve block (cFNB) within a multimodal analgesic in a TKA fast-track protocol. The study evaluated 95 patients on SSTS (SSTS group) and 87 on cFNB (cFNB/control group) and collected data on numeric rating scores for pain from day 1–3 after surgery (T1, T2, T3), both at rest (NRS) and during movement (mNRS), patient’s ability to walk, need for supplementary analgesia (rescue dose), occurrence of adverse effects, length of hospital stay, and usability rating for SSTS by both patients and hospital staff. RESULTS: NRS at rest was lower in the cFNB than in the SSTS group for all 3 days after surgery, whereas mNRS scores were lower in the SSTS group at all time points measured. Adverse effects were significantly fewer among patients of the SSTS group (6% patients) than those of the cFNB (74% patients) (p <  0.001). Rescue doses were needed by 5% of SSTS patients vs 60% of cFNB. The fewer adverse events and lower pain scores for the SSTS group were associated to a notably better ability to ambulate, with all patients (100%) of the SSTS group being able to stand and walk for 10 m from T1 on; patients in the cFNB group showed a slower recovery with only 40% being able to stand and walk on T1, 70% on T2 and 85% on T3. All patients of the SSTS group had a length of stay of 4 days (day of surgery plus 3 after) as foreseen by the fast track protocol, in comparison only 36% of cFNB. Lastly, patient and nursing staff judged SSTS easy to use. CONCLUSION: Our experience suggests that SSTS is a valuable strategy for routine postoperative analgesia following TKA in the context of a multimodal analgesic approach within the fast-track setting. Springer Berlin Heidelberg 2018-03-20 /pmc/articles/PMC5861254/ /pubmed/29557999 http://dx.doi.org/10.1186/s40634-018-0123-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Scardino, Marco
D’Amato, Tiziana
Martorelli, Federica
Fenocchio, Giorgia
Simili, Vincenzo
Di Matteo, Berardo
Bugada, Dario
Kon, Elizaveta
Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
title Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
title_full Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
title_fullStr Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
title_full_unstemmed Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
title_short Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
title_sort sublingual sufentanil tablet system zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861254/
https://www.ncbi.nlm.nih.gov/pubmed/29557999
http://dx.doi.org/10.1186/s40634-018-0123-y
work_keys_str_mv AT scardinomarco sublingualsufentaniltabletsystemzalvisoforpostoperativeanalgesiaafterkneereplacementinfasttracksurgeryapilotobservationalstudy
AT damatotiziana sublingualsufentaniltabletsystemzalvisoforpostoperativeanalgesiaafterkneereplacementinfasttracksurgeryapilotobservationalstudy
AT martorellifederica sublingualsufentaniltabletsystemzalvisoforpostoperativeanalgesiaafterkneereplacementinfasttracksurgeryapilotobservationalstudy
AT fenocchiogiorgia sublingualsufentaniltabletsystemzalvisoforpostoperativeanalgesiaafterkneereplacementinfasttracksurgeryapilotobservationalstudy
AT similivincenzo sublingualsufentaniltabletsystemzalvisoforpostoperativeanalgesiaafterkneereplacementinfasttracksurgeryapilotobservationalstudy
AT dimatteoberardo sublingualsufentaniltabletsystemzalvisoforpostoperativeanalgesiaafterkneereplacementinfasttracksurgeryapilotobservationalstudy
AT bugadadario sublingualsufentaniltabletsystemzalvisoforpostoperativeanalgesiaafterkneereplacementinfasttracksurgeryapilotobservationalstudy
AT konelizaveta sublingualsufentaniltabletsystemzalvisoforpostoperativeanalgesiaafterkneereplacementinfasttracksurgeryapilotobservationalstudy